J. Craig Venter Institute
JCVI is a 501(c)(3) nonprofit genomics and synthetic biology research institute with ~120 staff in La Jolla and Rockville, conducting federally funded research in human health, synthetic biology, environmental sustainability, and bioeconomy for the global scientific community.
- Company typePrivate
- Founded2004
- HeadquartersRockville, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What J. Craig Venter Institute does
J. Craig Venter Institute (JCVI) is a private 501(c)(3) nonprofit genomics and synthetic biology research institute headquartered in La Jolla, California with a second research facility in Rockville, Maryland. Founded through the 2004-2006 consolidation of the Center for the Advancement of Genomics (TCAG), the Institute for Biological Energy Alternatives (IBEA), and the J. Craig Venter Joint Technology Center, the institute carries forward the scientific legacy of J. Craig Venter, including the first free-living organism genome sequenced via whole-genome shotgun (1995), a draft human genome (2000), the first self-replicating synthetic bacterial cell (JCVI-syn1.0, 2010), and the first minimal synthetic cell with only 473 genes (JCVI-syn3.0, 2016). The institute employs approximately 120 scientists and staff organized across five research programs: Human Health, Environmental Sustainability, Synthetic Biology, Technology & Tools, and Policy Research.
JCVI's core technology stack spans whole-genome shotgun sequencing, synthetic genome construction and cell boot-up, multi-omics bioprospecting, and computational whole-cell modeling — including a 4D simulation of JCVI-syn3A published in Cell in 2026. Notable research outputs include the Global Ocean Sampling Expedition (millions of new genes), the ViPR open bioinformatics database, and the CIRCLE Global Center for waste-stream valorization and bioeconomy research. The institute serves the global scientific research community, federal funders (primarily NIH/PHS, NSF, DOE), and international research consortium partners.
JCVI's revenue model is grant-driven rather than commercial. The institute is the largest recipient of research funding from NIH and other Public Health Service agencies, supplemented by NSF and DOE grants, philanthropic donations (Genomic Frontier Fund), sponsored research agreements, and international consortium funding (e.g., CIRCLE with partners in Canada, Korea, and the UK). JCVI also operates commercial-adjacent vehicles including the 2026 spinout Diploid Genomics, Inc. (DGI) and historical minority holdings in Synthetic Genomics (now Viridos), Human Longevity, and SGI DNA (now Telesis Bio). Following founder J. Craig Venter's death in April 2026, leadership transitioned to President Anders Dale.
J. Craig Venter Institute firmographics
Firmographics- Name
- J. Craig Venter Institute
- Legal name
- J. Craig Venter Institute
- Website
- https://jcvi.org
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- JCVI is a 501(c)(3) nonprofit genomics and synthetic biology research institute with ~120 staff in La Jolla and Rockville, conducting federally funded research in human health, synthetic biology, environmental sustainability, and bioeconomy for the global scientific community.
- Ownership category
- akta.pro rank
J. Craig Venter Institute industry classification
Industry- Product category
- Genomics Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)
- akta.pro secondary industries
- Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)
Keywords
Where J. Craig Venter Institute is headquartered
LocationHeadquarters
- HQ city
- Rockville
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
J. Craig Venter Institute business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Federal Research Grants: Primary revenue source from federal agencies including the National Institutes of Health (NIH) and other Public Health Service (PHS) agencies. JCVI is the largest research funding recipient from NIH and PHS agencies. Funding also comes from NSF, DOE, and other federal sources.
- Philanthropy and Donations: The Genomic Frontier Fund provides unrestricted philanthropic support to JCVI programs and operating expenses. Donations are directed to areas of highest need including early stage research.
- Sponsored Research Agreements: Fee-for-service research collaborations with academic institutions, government agencies, and industry partners. Includes subcontracts from other research institutions.
- International Consortium Funding: Joint funding from international partners including NSF, Canadian agencies (NSERC, SSHRC), Korea's National Research Foundation, and UK Research and Innovation for the CIRCLE Global Center.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
J. Craig Venter Institute product offering
Product offeringCore offering
J. Craig Venter Institute (JCVI) is a nonprofit research organization that conducts genomics, synthetic biology, and bioinformatics research across four core programs: Human Health, Environmental Sustainability, Synthetic Biology, and Technology & Tools. JCVI delivers sponsored research services, develops synthetic genomes and minimal cells, performs high-throughput DNA sequencing, and operates open-access bioinformatics resources such as the Virus Pathogen Resource (ViPR) database. Its work is supported by federal grants (primarily NIH and NSF), philanthropy, and research collaborations with academic, government, and industry partners.
Product overview
The J. Craig Venter Institute is a not-for-profit research institute (501(c)(3)) with approximately 120 scientists and staff in La Jolla, California and Rockville, Maryland. JCVI does not offer a commercial product in the traditional SaaS sense; rather, it conducts genomics research across four core areas: Human Health (including cancer genomics and microbiome studies), Environmental Sustainability (including plastic degradation and bioeconomy research through CIRCLE), Synthetic Biology (including minimal cell development and genome synthesis), and Technology & Tools (high-throughput sequencing and bioinformatics). Key research outputs include the JCVI-syn3.0 minimal synthetic cell (473 genes, the smallest self-replicating organism) and JCVI-syn1.0 (first synthetic self-replicating cell). JCVI also maintains policy research programs on biosecurity and bioethics. The institute collaborates with academic and industry partners including the NSF Global Centers program, NIH, and international funding agencies.
Differentiator
Problem solved
Functional benefit
Brands
- CIRCLE: Center for Innovative Recycling and Circular Economy - NSF Global Center focused on waste-stream valorization and bioeconomy research
- Genomic Frontier Fund
Products and services
- Human Health Research Program Research program advancing understanding of human health and disease to enhance lives beyond managing health risks, including cancer genomics, human genome resequencing and analysis, and microbiome studies.
- Environmental Sustainability Research Program Research program that uses DNA sequencing, analysis, and synthetic biology techniques to harness microbes for environmental applications including plastic degradation and sustainable agriculture.
- Synthetic Biology Research Program Research program creating organisms with synthetic genomes, including minimal cells and genome design, construction, and boot-up capabilities.
- Center for Innovative Recycling and Circular Economy (CIRCLE) NSF Global Center focused on advancing bioeconomy research through waste-stream valorization, developing scalable solutions for plastic upcycling, C1 gas conversion, and biogenic waste valorization using multi-omics bioprospecting, computational protein engineering, and techno-economic analysis.
- Technology & Tools Research Program
Quantifiable outcome
- First draft human genome sequence completed in 2000, revolutionizing biomedical science
- +4 more outcomes
Companies that use J. Craig Venter Institute
Customer profileSegments4 records
Ideal customer profiles4 records
J. Craig Venter Institute technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature7 records
J. Craig Venter Institute partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered key and strategic.
- University of Illinois Urbana-ChampaignkeyResearch collaborator on 4D whole-cell model of minimal bacterium JCVI-syn3A, developing computational simulation of living cell.
- Harvard Medical SchoolkeyResearch collaborator on 4D whole-cell computational modeling project alongside JCVI and University of Illinois.
- PacBiostrategicSequencing technology provider for new startup Diploid Genomics, Inc. (DGI) - providing long-read sequencing technology for AI-driven genomics analytics.
- Oxford NanoporestrategicSequencing technology provider for Diploid Genomics, Inc. (DGI) - providing nanopore sequencing technology for diagnostic insights.
- Kansas State UniversitykeyAcademic partner in CIRCLE consortium with researcher Jikai Zhao, PhD contributing to waste valorization research.
- North Carolina A&T State UniversitykeyAcademic partner in CIRCLE consortium with researcher Reza Zadegan, PhD contributing to bioeconomy research.
- NC State UniversitykeyAcademic partner in CIRCLE consortium with researchers Sunkyu Park, PhD and Kai Lan, PhD contributing to synthetic biology and waste valorization.
- Keck Graduate InstitutekeyAcademic partner in CIRCLE consortium with researchers Saurav Datta, PhD and Gargi Ghosh, PhD contributing to bioprocess engineering.
- Columbia UniversitykeyAcademic partner in CIRCLE consortium with researcher Anum Glasgow, PhD contributing to computational biology approaches.
- Synthetic Genomics, Inc. (SGI)keyClose collaborator and spinout company focused on synthetic biology tools and services. Funded work on first synthetic cell and minimal cell research.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
J. Craig Venter Institute competitors and assessment
Company assessmentEmerging players
- Twist Bioscience: Commercial synthetic biology and DNA synthesis company. Comparable in synthetic biology and DNA technologies but operates as a public commercial entity focused on DNA synthesis rather than fundamental research.
- Ginkgo Bioworks: Public synthetic biology company operating commercial cell engineering platforms. Comparable in synthetic biology capability but operates as a for-profit enterprise that has commercialized many of the research areas JCVI pioneered.
Broad incumbents
- Wellcome Sanger Institute: Large-scale genomic sequencing and bioinformatics research institute in the UK, comparable as a globally leading genomics R&D organization with similar large-scale sequencing and bioinformatics capabilities, though broader in scope.
- Allen Institute: Nonprofit research organization founded with philanthropic support conducting large-scale science projects. Comparable in nonprofit R&D model and large-scale data generation, though focused on brain science and cell biology rather than synthetic biology.
Direct peers
- Broad Institute: Joint research institute of MIT and Harvard conducting large-scale genomic, synthetic biology, and biomedical research. Directly comparable as a major nonprofit genomics R&D organization with similar funding model (NIH, philanthropy) and overlapping research areas.
- Salk Institute for Biological Studies: Nonprofit biological research institute in La Jolla, CA with comparable headcount (~1,000+ scientists) and federal-grant-funded research model. Overlap in genomics, synthetic biology, and molecular biology research programs in the same geographic cluster.
- Scripps Research: Nonprofit biomedical research organization in La Jolla with similar scale and federal grant reliance. Comparable as a leading nonprofit research institute with overlapping work in chemistry, biology, and translational science.
- Whitehead Institute for Biomedical Research: Nonprofit biomedical research institute affiliated with MIT with comparable headcount and mission in fundamental biological research, including genomics and synthetic biology. Similar funding profile and research model.
- New York Genome Center: Nonprofit academic genomics research institute in New York conducting large-scale sequencing and multi-omics research. Comparable in nonprofit genomics R&D model, federal-grant funding, and collaborative research structure.
- Baylor College of Medicine Human Genome Sequencing Center: Major NIH-funded large-scale genome sequencing and genomics research center. Directly comparable as a nonprofit/academic genomics sequencing center with similar funding model and research output areas.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
J. Craig Venter Institute social profiles
Digital presenceJ. Craig Venter Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
J. Craig Venter Institute leadership team
Management profileNumber of profiles
Profiles8 records
J. Craig Venter Institute subsidiaries and ownership
Company hierarchySubsidiaries7 records
J. Craig Venter Institute funding detail
Funding detailFunding overview
Funding rounds5 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
J. Craig Venter Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about J. Craig Venter Institute
What does J. Craig Venter Institute do?
J. Craig Venter Institute (JCVI) is a nonprofit research organization that conducts genomics, synthetic biology, and bioinformatics research across four core programs: Human Health, Environmental Sustainability, Synthetic Biology, and Technology & Tools. JCVI delivers sponsored research services, develops synthetic genomes and minimal cells, performs high-throughput DNA sequencing, and operates open-access bioinformatics resources such as the Virus Pathogen Resource (ViPR) database. Its work is supported by federal grants (primarily NIH and NSF), philanthropy, and research collaborations with academic, government, and industry partners.
Is J. Craig Venter Institute a public or private company?
J. Craig Venter Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was J. Craig Venter Institute founded?
J. Craig Venter Institute was founded in 2004. It employs 101 to 250 people.
Where is J. Craig Venter Institute based?
J. Craig Venter Institute is headquartered in Rockville, United States, in the North America region.
How does J. Craig Venter Institute make money?
Four revenue lines are on record. Federal Research Grants are the primary driver. The others are philanthropy and Donations, sponsored Research Agreements and international Consortium Funding.
Who are J. Craig Venter Institute's main competitors?
Emerging players on record are Twist Bioscience and Ginkgo Bioworks. Broad incumbents are Wellcome Sanger Institute and Allen Institute. Direct peers are Broad Institute, Salk Institute for Biological Studies, Scripps Research, Whitehead Institute for Biomedical Research, New York Genome Center and Baylor College of Medicine Human Genome Sequencing Center.
Does J. Craig Venter Institute have an API?
No public API is recorded for J. Craig Venter Institute.
What industry is J. Craig Venter Institute in?
J. Craig Venter Institute's product category is Genomics Research Services. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAGANAE, Transcriptomics & Gene Expression Profiling Services. Its NAICS code is 541714 and its SIC code is 8731.